RecruitingEarly Phase 1NCT06538298

Title: A Multimodal Exercise Program With Gamification for Parkinson Disease (MEP+G)

A Multimodal Exercise Program With Gamification (MEP+G) in Individuals With Parkinson Disease: a Pilot Randomized Controlled Trial


Sponsor

California State University, Northridge

Enrollment

50 participants

Start Date

Sep 15, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

In this pilot study the research will explore whether exercises and the outcome measures would be acceptable to conduct a more detailed research study. This 8 week pilot study will utilize a comprehensive exercise program that includes non-contact boxing along with computerized games for individuals with Parkinson Disease.


Eligibility

Min Age: 40 YearsMax Age: 80 Years

Inclusion Criteria7

  • Hoehn and Yahr stages 1-3 disease as determined by primary care physician, neurologist, or movement disorder specialist
  • diagnosis of idiopathic Parkinson's Disease
  • ability to ambulate with or without an assistive device
  • transportation to and from testing site
  • ability to stand unassisted for 10 minutes
  • stable on Parkinson's disease medications for 3 months as determined by physician
  • medical clearance by their PCP, neurologist, or movement disorder specialist to participate in a moderate to vigorous exercise program.

Exclusion Criteria5

  • other neurological disease other than Parkinson's disease
  • having had deep brain stimulation within the past 3 months , as determined by their physician
  • currently participating in a Rock Steady boxing program
  • self-report participation in moderate to vigorous exercise greater than 60 minutes per week.
  • required

Interventions

OTHERMultimodal Exercise Program with Gamification

A comprehensive exercise program for 3 days a week for 6 weeks that utilizes non-contact boxing and gamification at moderate to vigorous intensity.


Locations(1)

Equilibrium Physical Therapy

Ventura, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06538298


Related Trials